REGN 2810

· Regeneron Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REGN 2810, covering 2026-06-25 to 2026-06-25. Get the full timeline:

Most recent: Clinical Trial Results: Study of REGN 2810 Compared to Platinum-Based Chemotherapies in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) [Phase 3]

See pricing